Testing effectiveness (Phase 2)Ended earlyNCT00322803
What this trial is testing
ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment
Who this might be right for
Panic Disorder
elbion AG 24